Support research using imaging, data and clinical trials to improve outcomes for people with multiple sclerosis

Support research using imaging, data and clinical trials to improve outcomes for people with multiple sclerosis

Give online
to support Support research using imaging, data and clinical trials to improve outcomes for people with multiple sclerosis

  • decorative

Dr Will Brown leads the Cambridge Big Data in Multiple Sclerosis group, a team dedicated to using data and advanced brain imaging to improve how MS is treated and how myelin repair is measured.

MS affects over 150,000 people in the UK, damaging the protective coating around nerve fibres and causing difficulties with movement, vision and thinking. Two of the biggest challenges in treating MS are knowing which treatment to give and when, and being able to tell whether repair is actually happening in the brain.

The group's research tackles both of these problems. By analysing data from thousands of patients across the world, the team works to identify which treatments work best and at what stage of the disease. They also develop specialised brain scanning techniques to detect subtle signs of damage and repair that are invisible on standard scans, and work to improve the tools used in clinical trials to measure whether myelin repair treatments are actually working.

Supporting this research will help people with MS receive the right treatments sooner and bring effective repair therapies closer to the clinic.

Next steps

You can support this research by giving a gift online now or to discuss your philanthropic objectives, please contact:

Make a gift now

Make a gift now to support W Brown Research Group by credit or debit card, or set up a direct debit:

Give online

Or, find out about other ways to give.

Belen Tejada-Romero

Head of Development, Brain and Mind Health

belen.tejadaromero@admin.cam.ac.uk

Leave a gift in your Will

Alice Macek

Associate Director, Legacies

legacies@philanthropy.cam.ac.uk

Find out more

This opportunity is part of

The Cambridge Clinical Multiple Sclerosis Research Group, based at the University of Cambridge, brings together clinicians and researchers with a single shared objective: to prevent and reverse disability in multiple sclerosis, neuromyelitis optica and related conditions.